Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2010
06/30/2010EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
06/30/2010EP1899307B1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010EP1476435B1 Novel pyridin- and pyrimidin-derivatives
06/30/2010EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors
06/30/2010EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
06/30/2010CN101765591A Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
06/30/2010CN101759684A Diaryl pyrimidine derivative, preparation method and use thereof
06/30/2010CN101759655A Conjugate of amino acid and pesticide, preparation method thereof and application as pesticide
06/30/2010CN101759654A 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof
06/30/2010CN101759653A Preparation method of 6, 7-dimethoxy quinazoline-4-ketone
06/30/2010CN101759652A Method for synthesizing spirocyclic compound
06/30/2010CN101759651A 4, 5-diaryl pyrimidine thiourea compound as well as preparation method and medical application thereof
06/30/2010CN101759650A Pyrimidine liquid crystal compounds and preparation method thereof
06/30/2010CN101759614A Preparation method of isothiocyanate
06/29/2010US7745662 Polycationic compounds and uses thereof
06/29/2010US7745458 (1S,5R)-3-[4-(4-phenyl-2-pyrimidinyl)butyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane, used for the treatment of drug abuse and dependence, urogenital disorders, as cognition activators and as antipsychotic agents
06/29/2010US7745454 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
06/29/2010US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
06/29/2010US7745445 Compounds and compositions as PPAR modulators
06/29/2010US7745436 Disalt inhibitors of IL-12 production
06/29/2010US7744910 Compounds and compositions for delivering active agents
06/29/2010CA2417942C 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
06/29/2010CA2383858C Substituted phenyl sulfamoyl carboxamides
06/24/2010WO2010070658A2 Improved process for the preparation of endothelin receptor antagonists
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010WO2010070365A1 1,3-heterocycles condensed with monoterpene skeleton, their use and pharmaceutical compositions comprising such compounds
06/24/2010US20100160630 Process for producing trichloropyrimidine compound
06/24/2010US20100160390 Compounds capable of activating cholinergic receptors
06/24/2010US20100160358 Pyridylsulfonamidyl-Pyrimidines for the Prevention of Blood Vessel Graft Failure
06/24/2010US20100160357 Heterobicyclic sphingosine 1-phosphate analogs
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160340 Protein kinase inhibitors
06/24/2010US20100160316 Quinazolines useful as modulators of ion channels
06/24/2010US20100160315 Novel 2, 3-diamino-quinazolinone derivatives and their medical use
06/24/2010US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore
06/24/2010US20100160290 Pharmaceutical composition for treating alzheimer's disease
06/24/2010US20100160283 Heteroaryl-substituted alkyne compounds and method of use
06/24/2010US20100160260 TRBD-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity
06/24/2010US20100159033 Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor
06/24/2010US20100158921 Compositions and methods for inhibition of the jak pathway
06/24/2010US20100158860 Heterocyclic antiviral compounds
06/24/2010CA2744888A1 Cysteine protease inhibitors
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197853A1 Insecticidal pyrimidinyl aryl hydrazones
06/23/2010EP1928857B1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives
06/23/2010CN1935793B Process for producing substituted aniline compound
06/23/2010CN1800169B Pemetrexed disodium key intermediate and its synthesis method, and method for synthesizing pemetrexed disodium from the said intermediate
06/23/2010CN101747283A Method for preparing 4,6 - dimethoxy -2 - methanesulfonyl pyrimidine
06/23/2010CN101747282A Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof
06/23/2010CN101104617B Dihydropyrimidine compounds and use of the same in preparing medicament for curing and preventing virosis
06/22/2010US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent
06/22/2010US7741484 5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine; using iodine monchloride for iodination, cyanoalkylation, hdyrogenation, cyclization; chemical intermediates; using guanidine carbonate, Brederick's reagent and aniline reagent
06/22/2010US7741482 Reference standard for characterization of rosuvastatin
06/22/2010US7741371 antiandrogens useful for suppressing spermatogenesis, treating hormone related conditions and prostate cancer; hormone inhibitors
06/22/2010US7741333 (3-bromophenyl)-(3,3-dioxo-2,3-dihydro-1H-3 lambda 6-thia-6,8-diazacyclopenta[a]naphthalen-9-yl)amine, uses as inhibitors of protein kinases
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010CA2541131C Derivatives of piperazine, process for their preparation and pharmaceutical compositions containing them
06/22/2010CA2514977C Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2439062C Silicon implants comprising a radionuclide for use in brachytherapy
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/17/2010WO2010068920A2 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010067008A2 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010066111A1 Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
06/17/2010WO2010025451A3 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
06/17/2010WO2009090661A9 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
06/17/2010US20100152442 4-anilino quinazoline derivatives as antiproliferative agents
06/17/2010US20100152218 Compositions and methods for inhibition of the jak pathway
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010CA2746701A1 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746427A1 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/16/2010EP2195459A2 Nucleobase characterisation
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP2195303A2 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
06/16/2010EP2195302A2 Insecticidal substituted azinyl derivatives
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists
06/16/2010EP2194985A1 Antimalarial compounds with flexible side-chains
06/16/2010CN1989141B Bicyclic heterocycles as HIV integrase inhibitors
06/16/2010CN1930134B Use of pyrimidine compounds in the preparation of parasiticides
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN1694871B Imidazolopyridines and methods of making and using the same
06/16/2010CN101743229A quinazolinamide derivatives
06/16/2010CN101743007A Inhibitors of akt/pkb with anti-tumor activity
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 427